Jeffrey Holford analyst

Currently out of the existing stock ratings of Jeffrey Holford, 96 are a BUY (82.05%), 19 are a HOLD (16.24%), 2 are a SELL (1.71%).

Jeffrey Holford

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Holford, carries an average stock price target met ratio of 93.38% that have a potential upside of 53.53% achieved within 1112 days. Previously, Jeffrey Holford worked at JEFFERIES, KEYBANK.

Jeffrey Holford’s has documented 229 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 14-Feb-2018.

Wall Street Analyst Jeffrey Holford

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/30/2012. The price target of $35 was fulfilled within 38 days with a profit of $2.16 (6.58%) receiving and performance score of 1.73.

Average potential price target upside

ABBV AbbVie ABT Abbott Laboratories AZN AstraZeneca PLC ADR BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer JNJ Johnson & Johnson ZTS Zoetis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2020

$338

$46.69 (16.03%)

$282

7 days ago
(02-Nov-2026)

20/21 (95.24%)

$43.11 (14.62%)

335

Buy Since 05-Feb-2020

$322

$30.69 (10.54%)

$288

7 days ago
(02-Nov-2026)

45/46 (97.83%)

$27.11 (9.19%)

407

Buy Since 08-Dec-2021

$340

$48.69 (16.71%)

$300

7 days ago
(02-Nov-2026)

10/13 (76.92%)

$45.11 (15.30%)

514

Buy Since 02-Nov-2026

$342

$50.69 (17.40%)

$206

7 days ago
(02-Nov-2026)

19/20 (95%)

$47.11 (15.98%)

376

Buy Since 25-Feb-2026

$330

$38.69 (13.28%)

$280

7 days ago
(02-Nov-2026)

7/8 (87.5%)

$35.11 (11.91%)

173

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?